Focus: Nebula Genomics is a consumer genomics company leveraging blockchain technology and personal data monetization to offer whole genome sequencing services. The company operates in the emerging direct-to-consumer genomics space with a focus on data ownership and privacy.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Growing — net +11 jobs in 30d
11 jobs added vs 0 removed. Steady team buildout.
Best suited for early-stage risk takers interested in biotech innovation rather than established career stability; significant execution risk warrants diligence on current funding and runway.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Nebula Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Nebula Genomics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub